“We are excited to have Advantage lead our retail launch. Retail expansion is a key component of our strategy, combined with an ongoing relationship with healthcare professionals,” stated Frank McGillin, NeuroMetrix SVP and general manager consumer. “Advantage demonstrated a unique understanding of the marketplace and how to create new categories within the major U.S. retailers. Their portfolio is primarily high growth, cutting edge brands such as Quell.”
“We are excited about the opportunity to utilize our experience to help NeuroMetrix launch Quell at retail," commented Greg Bradley, Advantage Consumer Healthcare president and CEO. "The time is right for their patented technology and we believe it can make a real difference for millions of Americans suffering from chronic pain.”
Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This first-of-its-kind wearable device utilizes NeuroMetrix’s patented, non-invasive nerve stimulation technology to provide drug-free pain relief. It is designed for people with nerve pain, sciatica, osteoarthritis and fibromyalgia, among other conditions. Quell is currently available through select healthcare professionals and online at www.QuellRelief.com.
Advantage Consumer Healthcare is a leading full-service sales, marketing and supply chain company with strong connections throughout the retail sector. The company specializes in launching new products into multiple distribution channels. One area of expertise is managing the transition of healthcare products from prescription to over-the-counter sales. The Advantage leadership team has successfully launched and managed more than 45 brands resulting in $2 billion in retail sales.